489 related articles for article (PubMed ID: 29627802)
1. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial.
Pollard DJ; Brennan A; Dixon S; Waugh N; Elliott J; Heller S; Lee E; Campbell M; Basarir H; White D;
BMJ Open; 2018 Apr; 8(4):e016766. PubMed ID: 29627802
[TBL] [Abstract][Full Text] [Related]
2. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model.
Kruger J; Brennan A; Thokala P; Basarir H; Jacques R; Elliott J; Heller S; Speight J
Diabet Med; 2013 Oct; 30(10):1236-44. PubMed ID: 23815547
[TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
[TBL] [Abstract][Full Text] [Related]
5. Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE).
REPOSE Study Group
BMJ; 2017 Mar; 356():j1285. PubMed ID: 28360027
[No Abstract] [Full Text] [Related]
6. The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trial.
White D; Waugh N; Elliott J; Lawton J; Barnard K; Campbell MJ; Dixon S; Heller S;
BMJ Open; 2014 Sep; 4(9):e006204. PubMed ID: 25186159
[TBL] [Abstract][Full Text] [Related]
7. A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective.
St Charles M; Lynch P; Graham C; Minshall ME
Value Health; 2009; 12(5):674-86. PubMed ID: 19171006
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial.
Li J; Parrott S; Sweeting M; Farmer A; Ross J; Dack C; Pal K; Yardley L; Barnard M; Hudda M; Alkhaldi G; Murray E
J Med Internet Res; 2018 Jun; 20(6):e201. PubMed ID: 29884608
[TBL] [Abstract][Full Text] [Related]
9. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
10. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC).
Herman WH; Braffett BH; Kuo S; Lee JM; Brandle M; Jacobson AM; Prosser LA; Lachin JM
J Diabetes Complications; 2018 Oct; 32(10):934-939. PubMed ID: 30064713
[TBL] [Abstract][Full Text] [Related]
11. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
12. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
13. Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada.
St Charles ME; Sadri H; Minshall ME; Tunis SL
Clin Ther; 2009 Mar; 31(3):657-67. PubMed ID: 19393856
[TBL] [Abstract][Full Text] [Related]
14. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
[TBL] [Abstract][Full Text] [Related]
15. Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal.
Tikhonova IA; Hoyle MW; Snowsill TM; Cooper C; Varley-Campbell JL; Rudin CE; Mujica Mota RE
Pharmacoeconomics; 2017 Mar; 35(3):363-373. PubMed ID: 27752999
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.
Leal J; Ahrabian D; Davies MJ; Gray LJ; Khunti K; Yates T; Gray AM
BMJ Open; 2017 Jan; 7(1):e013592. PubMed ID: 28069625
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United States.
Kamble S; Schulman KA; Reed SD
Value Health; 2012; 15(5):632-8. PubMed ID: 22867771
[TBL] [Abstract][Full Text] [Related]
18. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
[TBL] [Abstract][Full Text] [Related]
19. Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility Analysis.
Dawoud D; Fenu E; Higgins B; Wonderling D; Amiel SA
Value Health; 2017 Dec; 20(10):1279-1287. PubMed ID: 29241887
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of dapagliflozin as an adjunct to insulin for the treatment of type 1 diabetes mellitus in the United Kingdom.
Bennett H; Tank A; Evans M; Bergenheim K; McEwan P
Diabetes Obes Metab; 2020 Jul; 22(7):1047-1055. PubMed ID: 32037675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
